Exit·Construction/Engineering Services·June 9, 2026
Arlington Capital Partners sells Riverpoint Medical to Novanta
Brings a sponsor-owned medical device manufacturing asset into a corporate medical technology buyer, with valuation and operating scale not disclosed.
BuyerNovanta
TargetRiverpoint Medical
SponsorArlington Capital Partners
SellerArlington Capital Partners
TypeExit
IndustryConstruction
Sub-sectorEngineering Services
Novanta acquired Riverpoint Medical, a contract manufacturer of surgical sutures and orthopedic implants, from Arlington Capital Partners.
The transaction adds complex braided suture and implant manufacturing capabilities to Novanta's medical technology portfolio.
Daily PE deal brief
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.